These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1475778)

  • 1. Thrombin inhibition compared with other antithrombotic drugs in rats.
    Schumacher WA; Heran CH; Steinbacher TE; Megill JR; Bird JE; Giancarli MR; Durham SK
    Thromb Res; 1992 Oct; 68(2):157-66. PubMed ID: 1475778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.
    Schumacher WA; Steinbacher TE; Heran CL; Megill JR; Durham SK
    Thromb Haemost; 1993 May; 69(5):509-14. PubMed ID: 8322273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis.
    Schumacher WA; Heran CL; Youssef S; Megill JR; Michel I; Durham SK
    Haemostasis; 1993; 23(4):219-28. PubMed ID: 8314172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin.
    Schumacher WA; Steinbacher TE; Megill JR; Durham SK
    J Pharmacol Toxicol Methods; 1996 Feb; 35(1):3-10. PubMed ID: 8645878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents.
    Sugidachi A; Asai F; Tani Y; Hosokawa T; Koike H
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):57-64. PubMed ID: 8845464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats.
    Feuerstein GZ; Patel A; Toomey JR; Bugelski P; Nichols AJ; Church WR; Valocik R; Koster P; Baker A; Blackburn MN
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2554-62. PubMed ID: 10521387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.
    Hollenbach S; Sinha U; Lin PH; Needham K; Frey L; Hancock T; Wong A; Wolf D
    Thromb Haemost; 1994 Mar; 71(3):357-62. PubMed ID: 8029801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
    Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
    Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY
    Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity.
    Butler KD; Ambler J; Dolan S; Giddings J; Talbot MD; Wallis RB
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):155-65. PubMed ID: 1606287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
    Mellott MJ; Connolly TM; York SJ; Bush LR
    Thromb Haemost; 1990 Dec; 64(4):526-34. PubMed ID: 2128137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thrombin inhibition in a rat arterial thrombosis model.
    Broersma RJ; Kutcher LW; Heminger EF
    Thromb Res; 1991 Nov; 64(4):405-12. PubMed ID: 1788827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN; Girard D; Lochot S; Lecoffre C
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.
    Lam JY; Chesebro JH; Steele PM; Heras M; Webster MW; Badimon L; Fuster V
    Circulation; 1991 Aug; 84(2):814-20. PubMed ID: 1830520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
    Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
    Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
    Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
    Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.